Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2
Ependymoma Hub
V1V2
Sign in
← Cases

Gedatolisib

883a36c3-1cb5-5944-b814-84c3f8ef0d51 · Phase III FDA Trials · targets PI3K, MTOR_FRAP1

Gedatolisib

MeasuredReference

Gedatolisib targets MTOR_FRAP1.

Primary targets

MTOR_FRAP1

Top hallmarks

No hallmark data.

Top pathways disrupted

No pathway data.

Resistance landscape — Gedatolisib

MeasuredReference

10 known oncogenic variants exist on Gedatolisib's top targets — see detail for inhibition impact.

Open in new tab